Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3644017
Max Phase: Preclinical
Molecular Formula: C24H26N8O
Molecular Weight: 442.53
Molecule Type: Small molecule
Associated Items:
ID: ALA3644017
Max Phase: Preclinical
Molecular Formula: C24H26N8O
Molecular Weight: 442.53
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(Cc1cccc(-c2cnc(N3CCN(c4ccc(C#N)nc4)CC3)nc2)c1)C(=O)CN
Standard InChI: InChI=1S/C24H26N8O/c1-30(23(33)13-26)17-18-3-2-4-19(11-18)20-14-28-24(29-15-20)32-9-7-31(8-10-32)22-6-5-21(12-25)27-16-22/h2-6,11,14-16H,7-10,13,17,26H2,1H3
Standard InChI Key: XDABGJRXAMEIOF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 442.53 | Molecular Weight (Monoisotopic): 442.2230 | AlogP: 1.65 | #Rotatable Bonds: 6 |
Polar Surface Area: 115.27 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.13 | CX LogP: 1.49 | CX LogD: 0.69 |
Aromatic Rings: 3 | Heavy Atoms: 33 | QED Weighted: 0.61 | Np Likeness Score: -1.59 |
1. (2014) Glycine compound, |
Source(1):